Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Single/Multiple Dose Study of SSJG-009 in Healthy Japanese Adult Males
jRCT2051240138Phase 1Completed
- Sponsor
- Sunstar
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing SSJG-009 treatment group with Placebo group (2 arms). Primary endpoints: Safety and Pharmacokinetics. Started Oct 2024; status: completed.
02
Drugs
SSJG-009
Beyond the preview
Go deeper on jRCT2051240138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051240138.